support

Technical Support


Phone: (410) 638-9239

Fax: (410) 638-6108

GoToMeeting: Meet Now!

Web: www.CadmiumCD.com

Submit Support Ticket


close this panel
‹‹ Go Back

Dashiell F. Young-Saver

Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine at the University of California



‹‹ Go Back

Jeffrey Gornbein

Department of Biomathematics, University of California



‹‹ Go Back

Sidney Starkman

Departments of Emergency Medicine and Neurology and Comprehensive Stroke Center, David Geffen School of Medicine at the University of California



‹‹ Go Back

Jeffrey L. Saver

Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine at the University of California



‹‹ Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

←Back IconGems-Print

359 – Contributed Poster Presentations: Biopharmacutical Section

Handling of Missing Outcome Data in Acute Stroke Trials: Advantages of Multiple Imputation Using Baseline and Post-Baseline Variables

Sponsor: Biopharmaceutical Section
Keywords: Missing Data, Imputation, Last Observation Carried Forward, Multiple Imputation, Stroke, Clinical Trial

Dashiell F. Young-Saver

Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine at the University of California

Jeffrey Gornbein

Department of Biomathematics, University of California

Sidney Starkman

Departments of Emergency Medicine and Neurology and Comprehensive Stroke Center, David Geffen School of Medicine at the University of California

Jeffrey L. Saver

Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine at the University of California

Multiple imputation (MI) is a preferred approach to missing outcome data in longitudinal studies of progressive disease; older techniques, like complete case analysis (CCA) and last observation carried forward (LOCF), can bias toward unduly good outcomes. But the preferred approach for studies of acute illnesses with some recovery, such as acute stroke, is understudied. In these settings, CCA and LOCF may bias toward worse group outcomes than actually occur. Therefore, these methods are viewed as "conservative" and remain often used. Using data from a well-known acute stroke trial, we simulated data missingness and compared 5 handling methods: 1) CCA, 2) worst outcome assigned, 3) LOCF, 4) MI using baseline covariates (BCVs), and 5) MI using BCVs plus later observed outcomes. Imputation methods that ignored post-baseline data showed poor correlation with actual outcomes and reduced study power. LOCF preserved power but biased outcome estimates to worse than actual. MI with BCVs plus interim outcome observations yielded highest power, accuracy, and lack of directional bias. We describe techniques to assess bias and variance of imputation methods in acute illness trials generally.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2018 CadmiumCD